Medicine
Aprepitant 80 mg capsule
Aprepitant 80 mg capsule is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Aprepitant
- Brand
- Sold under the generic name
- Strength
- 80 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 2 capsules, 1 blister pack, 2 blister pack and 7 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaTorrent PharmaceuticalsIndiaBluePoint LaboratoriesGolden State Medical SupplySandoz
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD12 Fosaprepitant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 December 2016
- Identifiers
- RxCUI 403810, 403811, 644088 +1DailyMed set ID a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4, d72e0e10-4557-41b0-b65d-d395468cad19, f58b8944-93ee-4be1-a238-cc0061ddd93a +1NDC 13668-592, 68001-667, 68462-584 +2Application ANDA211835, ANDA207777, ANDA090999
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 capsule in 1 dose pack | 68462-584-58 | Glenmark PharmaceuticalsIndia | 12 October 2017 |
| 1 blister pack in 1 carton / 6 capsule in 1 blister pack | 68462-584-76 | Glenmark PharmaceuticalsIndia | 12 October 2017 |
| 2 blister pack in 1 carton / 1 capsule in 1 blister pack | 13668-592-84 | Torrent PharmaceuticalsIndia | 21 October 2020 |
| 3 blister pack in 1 carton / 2 capsule in 1 blister pack | 13668-592-86 | Torrent PharmaceuticalsIndia | 21 October 2020 |
| 2 capsule in 1 dose pack | 0781-2322-46 | Sandoz | 27 December 2016 |
| 1 blister pack in 1 carton / 6 capsule in 1 blister pack | 0781-2322-68 | Sandoz | 27 December 2016 |
| 2 capsule in 1 dose pack | 68001-667-01 | BluePoint Laboratories | 2 February 2026 |
| 1 blister pack in 1 carton / 6 capsule in 1 blister pack | 68001-667-19 | BluePoint Laboratories | 29 January 2026 |
| 2 blister pack in 1 carton / 1 capsule in 1 blister pack | 51407-702-02 | Golden State Medical Supply | 11 June 2025 |
| 3 blister pack in 1 carton / 2 capsule in 1 blister pack | 51407-702-06 | Golden State Medical Supply | 11 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Aprepitant 80 mg capsule.
Other strengths and forms of Aprepitant
Clinical summary
Aprepitant is a substance P/neurokinin-1 receptor antagonist. It is available as capsules, injectable emulsion and kits for oral and intravenous use. MedsAcross supplies Aprepitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AprepitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EMEND prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Emend: European public assessment report (EPAR) · European Medicines Agency
Need Aprepitant 80 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.